Chemokine receptor activity regulator

Chemokine receptor activity regulator

Provided is a chemokine receptor activity regulator, etc. containing as the effective component thereof a pyrazolopyrimidine derivative indicated by formula (I) or a pharmaceutically acceptable salt thereof {in the formula, R1 indicates -NR1aR1b (in the formula, R1a and R1b are the same or different...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YAMAMOTO, KEISUKE, MIZUTANI, MIRAI, SENO, YUKO, ARATAKE, SEIJI, HEMMI, KAZUKI
Format: Patent
Sprache:chi ; eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YAMAMOTO, KEISUKE
MIZUTANI, MIRAI
SENO, YUKO
ARATAKE, SEIJI
HEMMI, KAZUKI
description Provided is a chemokine receptor activity regulator, etc. containing as the effective component thereof a pyrazolopyrimidine derivative indicated by formula (I) or a pharmaceutically acceptable salt thereof {in the formula, R1 indicates -NR1aR1b (in the formula, R1a and R1b are the same or different, and indicate a hydrogen atom, an aralkyl, etc.), R2 indicates (II) [in the formula, k and m each indicate an integer between 0 and 2, n indicates an integer between 0 and 2, L indicates a single bond, etc., R5 indicates halogen, etc., R6 indicates aryl, etc., x indicates -CR8 (in the formula, R8 indicates a hydrogen atom, etc.), etc., R7 indicates a hydrogen atom, etc.,] etc., R3 indicates -SO2R13 [in the formula, R13 indicates a lower alkoxy, -NR13d(C=0)R13e (in the formula, R13d indicates a hydrogen atom, etc., R13e indicates a lower alkyl, etc.,) etc.,] and R4 indicates a hydrogen atom, etc.}.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW201311693A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW201311693A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW201311693A3</originalsourceid><addsrcrecordid>eNrjZFB1zkjNzc_OzEtVKEpNTi0oyS9SSEwuySzLLKkEiqSX5iQChXgYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxIuJGBobGhoZmlsaMxMWoAdEAnzQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Chemokine receptor activity regulator</title><source>esp@cenet</source><creator>YAMAMOTO, KEISUKE ; MIZUTANI, MIRAI ; SENO, YUKO ; ARATAKE, SEIJI ; HEMMI, KAZUKI</creator><creatorcontrib>YAMAMOTO, KEISUKE ; MIZUTANI, MIRAI ; SENO, YUKO ; ARATAKE, SEIJI ; HEMMI, KAZUKI</creatorcontrib><description>Provided is a chemokine receptor activity regulator, etc. containing as the effective component thereof a pyrazolopyrimidine derivative indicated by formula (I) or a pharmaceutically acceptable salt thereof {in the formula, R1 indicates -NR1aR1b (in the formula, R1a and R1b are the same or different, and indicate a hydrogen atom, an aralkyl, etc.), R2 indicates (II) [in the formula, k and m each indicate an integer between 0 and 2, n indicates an integer between 0 and 2, L indicates a single bond, etc., R5 indicates halogen, etc., R6 indicates aryl, etc., x indicates -CR8 (in the formula, R8 indicates a hydrogen atom, etc.), etc., R7 indicates a hydrogen atom, etc.,] etc., R3 indicates -SO2R13 [in the formula, R13 indicates a lower alkoxy, -NR13d(C=0)R13e (in the formula, R13d indicates a hydrogen atom, etc., R13e indicates a lower alkyl, etc.,) etc.,] and R4 indicates a hydrogen atom, etc.}.</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130316&amp;DB=EPODOC&amp;CC=TW&amp;NR=201311693A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130316&amp;DB=EPODOC&amp;CC=TW&amp;NR=201311693A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAMAMOTO, KEISUKE</creatorcontrib><creatorcontrib>MIZUTANI, MIRAI</creatorcontrib><creatorcontrib>SENO, YUKO</creatorcontrib><creatorcontrib>ARATAKE, SEIJI</creatorcontrib><creatorcontrib>HEMMI, KAZUKI</creatorcontrib><title>Chemokine receptor activity regulator</title><description>Provided is a chemokine receptor activity regulator, etc. containing as the effective component thereof a pyrazolopyrimidine derivative indicated by formula (I) or a pharmaceutically acceptable salt thereof {in the formula, R1 indicates -NR1aR1b (in the formula, R1a and R1b are the same or different, and indicate a hydrogen atom, an aralkyl, etc.), R2 indicates (II) [in the formula, k and m each indicate an integer between 0 and 2, n indicates an integer between 0 and 2, L indicates a single bond, etc., R5 indicates halogen, etc., R6 indicates aryl, etc., x indicates -CR8 (in the formula, R8 indicates a hydrogen atom, etc.), etc., R7 indicates a hydrogen atom, etc.,] etc., R3 indicates -SO2R13 [in the formula, R13 indicates a lower alkoxy, -NR13d(C=0)R13e (in the formula, R13d indicates a hydrogen atom, etc., R13e indicates a lower alkyl, etc.,) etc.,] and R4 indicates a hydrogen atom, etc.}.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB1zkjNzc_OzEtVKEpNTi0oyS9SSEwuySzLLKkEiqSX5iQChXgYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxIuJGBobGhoZmlsaMxMWoAdEAnzQ</recordid><startdate>20130316</startdate><enddate>20130316</enddate><creator>YAMAMOTO, KEISUKE</creator><creator>MIZUTANI, MIRAI</creator><creator>SENO, YUKO</creator><creator>ARATAKE, SEIJI</creator><creator>HEMMI, KAZUKI</creator><scope>EVB</scope></search><sort><creationdate>20130316</creationdate><title>Chemokine receptor activity regulator</title><author>YAMAMOTO, KEISUKE ; MIZUTANI, MIRAI ; SENO, YUKO ; ARATAKE, SEIJI ; HEMMI, KAZUKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW201311693A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YAMAMOTO, KEISUKE</creatorcontrib><creatorcontrib>MIZUTANI, MIRAI</creatorcontrib><creatorcontrib>SENO, YUKO</creatorcontrib><creatorcontrib>ARATAKE, SEIJI</creatorcontrib><creatorcontrib>HEMMI, KAZUKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAMAMOTO, KEISUKE</au><au>MIZUTANI, MIRAI</au><au>SENO, YUKO</au><au>ARATAKE, SEIJI</au><au>HEMMI, KAZUKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Chemokine receptor activity regulator</title><date>2013-03-16</date><risdate>2013</risdate><abstract>Provided is a chemokine receptor activity regulator, etc. containing as the effective component thereof a pyrazolopyrimidine derivative indicated by formula (I) or a pharmaceutically acceptable salt thereof {in the formula, R1 indicates -NR1aR1b (in the formula, R1a and R1b are the same or different, and indicate a hydrogen atom, an aralkyl, etc.), R2 indicates (II) [in the formula, k and m each indicate an integer between 0 and 2, n indicates an integer between 0 and 2, L indicates a single bond, etc., R5 indicates halogen, etc., R6 indicates aryl, etc., x indicates -CR8 (in the formula, R8 indicates a hydrogen atom, etc.), etc., R7 indicates a hydrogen atom, etc.,] etc., R3 indicates -SO2R13 [in the formula, R13 indicates a lower alkoxy, -NR13d(C=0)R13e (in the formula, R13d indicates a hydrogen atom, etc., R13e indicates a lower alkyl, etc.,) etc.,] and R4 indicates a hydrogen atom, etc.}.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_TW201311693A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Chemokine receptor activity regulator
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T03%3A29%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAMAMOTO,%20KEISUKE&rft.date=2013-03-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW201311693A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true